UMC Governing Board Audit & Finance Committee
Summary
FY20 loss $63.1M; July loss $8.2M; COVID surge drives staffing gaps.
What Matters to Employees 9 items
Emergency purchase for COVID PPE supplies.
Leading clinical trial site; financial benefits shown.
June loss $41.7M; FY20 loss $63.1M; July loss $8.2M.
Extension and rate increase for managed care.
Emergency staffing for nurses and lab techs due to COVID surge.
Emergency lease for non-essential supplies.
Staff augmentation for med techs and couriers.
Consolidated orthopaedic on-call and clinical services.
New contract for primary care and infectious disease.
All Agenda Items 13 items
On track; budget details discussed; risk mitigation in place.
Admissions -9.5%; labor +$7.7M; cash on hand 54.1 days.
No impact to UMC; private hospitals may face 15% fee.
Ratification for anesthesia/ortho reimbursement.
Adds orthopedic and anesthesia professional fees.
Extends term 24 months; updates reimbursement.
Adds orthopedic and anesthesia professional services.
Extends term; increases NTE for renovation projects.
Sole respondent; 3-year term with extensions.
Increases funding for pest control at new locations.
Approval to purchase property; closing pending.
Adds pancreas transplant; increases funding due to volume.
Additional space, parking, extended term to 2028.